Sankala Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.03K Sell
14
-5
-26% -$1.64K ﹤0.01% 445
2025
Q4
$6.08K Buy
+19
New +$6.42K ﹤0.01% 436

Other funds holding ELV

Sankala Group's ELV Position: Q1 2026 in Review

Sankala Group reduced its Elevance Health (ELV) stake by 26% in Q1 2026, selling an estimated $1.64K and leaving 14 shares worth $4.03K. The position accounts for ﹤0.01% of the portfolio, ranked #445.

Sankala Group first reported a position in ELV in Q4 2025 and has held it in 2 quarters since. The position peaked at $6.08K in Q4 2025. 1,467 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Sankala Group held 14 shares of Elevance Health worth $4.03K as of Q1 2026.
  • Sankala Group sold 5 Elevance Health shares in Q1 2026, an estimated $1.64K.
  • Elevance Health made up ﹤0.01% of Sankala Group's portfolio in Q1 2026, its #445 holding.
  • Sankala Group first reported a position in Elevance Health in Q4 2025 and has held it in 2 quarters since.
  • Sankala Group's Elevance Health position peaked at $6.08K in Q4 2025.
  • 1,467 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Sankala Group's 13F filing for Q1 2026, filed 31 Mar 2026.